Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.48 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.37 |
| ▸ | AGBL2 | Q5U5Z8 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.36 |
| ▸ | FLT1 | P17948 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.35 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.35 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.35 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.35 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.35 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.35 |
| ▸ | PTGES | O14684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6605540 | 0.84 | PTGDR2 (0.37) | PTGDR2EGLN1PTPN1PTPN6PTPN11 | |
| SCHEMBL14937930 | 0.74 | MEN1 (0.41) | — | |
| SCHEMBL14938139 | 0.73 | CA12 (0.48) | — | |
| SCHEMBL14938295 | 0.72 | CA1 (0.44) | PTPN6FLT1KDR | |
| SCHEMBL14938278 | 0.71 | KIF11 (0.38) | — | |
| SCHEMBL14937812 | 0.71 | CA12 (0.43) | — | |
| SCHEMBL4359176 | 0.71 | POLB (0.39) | — | |
| SCHEMBL14938305 | 0.71 | PDE2A (0.41) | — | |
| SCHEMBL14937804 | 0.70 | PDE2A (0.33) | PTGDR2EGLN1 | |
| SCHEMBL14937750 | 0.69 | CA2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1219173-B1 | INSECTICIDES AND ACARICIDES | AGRO KANESHO CO LTD (JP) | 2004-06-16 | — | — | EP | disclosed |
| US-20020156115-A1 | Insecticidal and acaricidal composition, and methods of using the same | AGRO-KANESHO CO., LTD. (JP) | 2002-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156115-A1 | Insecticidal and acaricidal composition, and methods of using the same | GSTO1, CBR3, CBR1 | PTGDR2 1223/4885EGLN1 191/4885FFAR1 1369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.